Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Database
Language
Document Type
Year range
1.
Nat Microbiol ; 6(12): 1467-1468, 2021 12.
Article in English | MEDLINE | ID: covidwho-1663977
2.
Future Microbiol ; 16: 615-618, 2021 06.
Article in English | MEDLINE | ID: covidwho-1262586

ABSTRACT

This interview was conducted by Atiya Henry, Commissioning Editor of Future Microbiology. Joseph M Blondeau, MSc, PhD, RSM(CCM), SM(AAM), SM(ASCP), FCCP is a Clinical Microbiologist and Head of Clinical Microbiology at Royal University Hospital (Saskatoon Health Region) and the University of Saskatchewan in Saskatoon, Canada. He is also the Provincial Clinical Lead for Microbiology in Saskatchewan, Canada. He holds a Masters of Sciences in Microbiology from Dalhousie University (1985) and a Doctor of Philosophy in Medical Microbiology from the University of Manitoba (1989). Following completion of his PhD, he completed an 1-month post-doctoral training in an infectious diseases research laboratory at Dalhousie University and following which he completed a 2-year post-doctoral residency training program in Clinical Microbiology, also at Dalhousie University. He holds appointments as a Clinical Associate Professor of Pathology, Adjunct Professor of Microbiology and Immunology and Clinical Associate Professor of Ophthalmology. He teaches to undergraduate and graduate students in the areas of microbiology, infectious diseases, antimicrobial agents and pharmacology. Dr Blondeau's main research interests are in the area of antimicrobial agents and antimicrobial resistance, clinical microbiology and clinical outcomes associated with antimicrobial therapy in both human and veterinary medicine.


Subject(s)
COVID-19 , Clinical Medicine , Microbiology , Clinical Medicine/history , Clinical Medicine/trends , Forecasting , History, 20th Century , History, 21st Century , Humans , Laboratories , Microbiology/history , Microbiology/trends
4.
J Leukoc Biol ; 109(3): 513-517, 2021 03.
Article in English | MEDLINE | ID: covidwho-1100872

ABSTRACT

Metchnikoff's essay, Intestinal Bacteriotherapy, was written when the study of microbiology was still in its infancy and few intestinal diseases had been ascribed to a specific bacterial infection. Metchnikoff offered perceptive ideas that have become standard in today's science. This Historical Perspectives commentary examines how Metchnikoff's article influenced our field. An accompanying editorial by Siamon Gordon explores this topic further and describes the relevance of Metchnikoff's work to the current Covid-19 infection. We also include a translation of this fundamental article by Metchnikoff, as presented by Claudine Neyen.


Subject(s)
Gastrointestinal Microbiome/physiology , Microbiology/history , Animals , COVID-19 , History, 19th Century , History, 20th Century , Humans , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL